Thanks to new transparency requirements, payers now have to publicly report their prior authorization data. The numbers are in, and they should make you furious.
More than 80% of prior authorization denials that are appealed get overturned.
Four out of five times, when a doctor pushes back on a denial, the insurance company reverses course and says, “Fine. Yes. The care is medically necessary.”
The denial is the feature
If 80% of appealed denials are eventually approved, the initial denial wasn’t a medical decision. It was a bet — a bet that the doctor wouldn’t have time to fight it, and a bet that the patient would give up.
That bet pays off constantly. The AMA reports that 78% of physicians have seen patients abandon treatment entirely because of prior authorization. Not because the treatment wasn’t needed. Because the process broke them.
Think about what that means. The system is designed so that the default answer is “no,” and the only way to get to “yes” is to have the time, energy, and staffing to fight.
Who gets hurt
The impact isn’t evenly distributed. Consider who has the resources to appeal:
- Large health systems with dedicated prior auth teams can fight denials systematically. They have the staff, the infrastructure, and the institutional knowledge to push back.
- Small practices with two admin staff? They’re triaging. Every hour spent on an appeal is an hour not spent on the next patient’s authorization. Something has to give.
- Patients who are already sick, exhausted, and navigating a system they don’t understand? Many simply stop trying.
The cruelty is structural. The patients most likely to abandon necessary care are the ones who are already the most vulnerable — the sickest, the most under-resourced, the least able to advocate for themselves.
What the transparency data reveals
The new public reporting requirements are exposing what many in healthcare have known anecdotally for years:
- Denial rates vary wildly between payers, suggesting that clinical criteria are applied inconsistently
- The majority of denials don’t survive scrutiny — when challenged with the same clinical evidence, payers reverse their decisions
- The administrative cost of the deny-appeal cycle is enormous, and ultimately borne by providers and patients
This data makes the economic argument for prior authorization harder to defend. If the process costs billions in administrative overhead and the majority of denials are eventually overturned, the system isn’t controlling costs — it’s generating them.
The appeal shouldn’t be necessary
The solution isn’t to get better at appealing. The solution is to make the initial submission so complete, so clinically precise, and so well-matched to payer requirements that the denial doesn’t happen in the first place.
That’s the approach we’re taking at Artificer Health. We’re building a platform that uses AI to match clinical documentation to payer-specific criteria, assembling submissions that address the most common denial triggers before they’re even submitted.
We don’t think “authorization” should mean “obstacle.” We think it should mean “handled.”
Sources: